The journal adheres to the core practices of the Committee on Publication Ethics  and follows COPE guidelines which outline how to deal with cases of potential publication misconduct.

The World Association of Medical Editors and the recommendations of the International Committee of Medical Journal Editors are followed and outline the expected duties of editors, reviewers and authors.

All submissions must conform to the International Committee of Medical Journal Editors uniform requirements for manuscripts submitted to biomedical journals. The journal requirements reflect those of the ICMJE.

Research ethics committee approval

Authors must provide evidence of Research Ethics Committee approval of the research where relevant and ensure the correct, full ethics committee name and reference number is included in the manuscript.

If the study was carried out using data from provincial healthcare facilities, or required active data collection through facility visits or staff interviews, approval should be sought from the relevant provincial authorities. For South African authors, please refer to the guidelines for submission to the National Health Research Database. Research involving human participants must be conducted according to the principles outlined in the current version of the Declaration of Helsinki. Please refer to the National Department of Health’s guideline on Ethics in Health Research: principles, processes and structures to ensure that the appropriate requirements for conducting research have been met, and that the HPCSA’s General Ethical Guidelines for Health Researchers have been adhered to.

Clinical trials

As per the recommendations published by the International Committee of Medical Journal Editors (ICMJE), clinical trial research is any research that assigns individuals to an intervention, with or without a concurrent comparison/control group to study the cause-and-effect relationship between the intervention and health outcomes. All clinical trials should be registered with the appropriate national clinical trial registry (or any international primary register, if relevant), and the trial registration number should be cited at the end of the abstract. All clinical trial reports must also contain a data sharing statement as per the recommendations of the ICMJE. Statements are to indicate:

• whether individual deidentified participant data will be shared;
• what data in particular will be shared; whether additional, related documents will be available;
• when the data will become available and for how long; by what access criteria data will be shared.

Please see the ICJME announcement for further details and illustrative examples of data sharing statements: ICMJE Data Sharing Statements for Clinical Trials

 

Patient Consent

Information that would enable identification of individual patients should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) has given informed written consent for publication and distribution. We further recommend that the published article is disseminated not only to the involved researchers but also to the patients/participants from whom the data was drawn. Refer to Protection of Research Participants. The signed consent form should be submitted with the manuscript to enable verification by the editorial team.

Other individuals

Any individual who is identifiable in an image must provide written agreement that the image may be used in that context in the AJHPE.